Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;37(1):9-17.
doi: 10.1007/s00774-018-0971-7. Epub 2018 Oct 24.

Regulatory mechanisms of sclerostin expression during bone remodeling

Affiliations
Review

Regulatory mechanisms of sclerostin expression during bone remodeling

Masanori Koide et al. J Bone Miner Metab. 2019 Jan.

Abstract

Osteocytes are embedded in bone matrices and are connected to each other to respond to mechanical loading on bone. Recent studies have demonstrated the roles of mechanical loading in bone accrual. Bone responds to mechanical loading by decreasing the expression of sclerostin, an inhibitor of Wnt/β-catenin signals, in osteocytes. This increases bone mass because the activation of Wnt/β-catenin signals in bone microenvironments promotes bone formation and suppresses bone resorption. Thus, in recent years, sclerostin have attracted increasing attention in bone metabolism. However, the regulatory mechanism of sclerostin expression during bone remodeling has not been fully elucidated. In this review, we summarized the regulation of bone formation and resorption by Wnt signals, a Wnt/β-catenin signal inhibitor sclerostin, and molecular mechanisms by which the expression of sclerostin is suppressed by mechanical loading and parathyroid hormone. We also discuss a possibility that osteoclasts suppress the expression of sclerostin during bone remodeling, which in turn, promote bone formation. The effectiveness of an anti-sclerostin antibody with anti-dickkopf-1 antibody for increasing bone mass was discussed.

Keywords: Bone remodeling; Osteoblasts; Osteoclasts; Osteocytes; Sclerostin.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Endocr Rev. 1999 Jun;20(3):345-57 - PubMed
    1. J Bone Miner Res. 1999 Jul;14(7):1239-49 - PubMed
    1. Nature. 1999 Nov 18;402(6759):304-9 - PubMed
    1. Am J Hum Genet. 2001 Mar;68(3):577-89 - PubMed
    1. Hum Mol Genet. 2001 Mar 1;10(5):537-43 - PubMed

LinkOut - more resources